| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.21 | 8e-06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.003 |